Inventiva (IVA) Share-based Compensation (2019 - 2022)

Inventiva (IVA) posted quarterly Share-based Compensation of $1.7 million for Q4 2022, up 8585.42% quarter-over-quarter from $19299.8 in Q1 2021.

Analysis

Inventiva (IVA) Share-based Compensation (2019 - 2022) Analysis & Trends

Inventiva's Share-based Compensation history runs 3 years deep, the most recent figure standing at $1.7 million for Q4 2022.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	108.10 Mn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	243.00 Mn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	120.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	277.20 Mn
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	137.41 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	86.63 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	41.25 Mn
10	Inventiva	893.85 Mn	893.85 Mn	-	-

Historic Data

Download Data